Abstract
Familial Mediterranean fever (FMF) is an autosomal recessive disease, characterized by recurrent, self-limited attacks of fever with serositis involving the peritoneum, pleura, and joints. There is very scarce information on physical growth of affected children. The aim of this study was to determine whether there is significant improvement in growth parameters in FMF patients after colchicine treatment. Patient files were retrospectively evaluated and patients that used colchicine for more than 1 year were included in the study. Demographic features, clinical findings before and after colchicine therapy, duration and dosage of therapy, weight, height, parentally adjusted height, and body mass index before and after colchicine therapy were noted and transformed into standard deviation scores (SDS). The study group consisted of 50 FMF (25 male and 25 female) patients. Median age at the time of diagnosis was 6.5 years. Median follow-up period was 3.6 (1–12.5) years. Mean height SDS increased from −0.19 ± 1.01 to 0.13 ± 0.99 (p = 0.026), and mean parentally adjusted height increased from −0.18 ± 1.23 to 0.13 ± 1.24 (p = 0.027), and both of them were found to be statistically significant. Mean body mass index SDS increased from −0.61 ± 1.32 to −0.32 ± 1.33, but this improvement was statistically insignificant (p = 0.18). In this study, we found that colchicine significantly improved height development in FMF patients.
Similar content being viewed by others
References
Ahmed SF, Wong JS, McGrogan P (2007) Improving growth in children with inflammatory bowel disease. Horm Res 68(Suppl 5):117–121
Ben-Chetrit E, Levy M (1991) Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 20:241–246
Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664
Korkmaz C, Özdoğan H, Kasapçopur Ö, Yazıcı H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81
Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885
Livneh A, Langevitz P, Zemer D et al (1997) Establishment of a new set of criteria for the classification of familial Mediterranean fever. In: Sohar E, Gafni J, Pras M (eds) First international conference on familial Mediterranean fever (FMF) (abstract book). Freund, London, pp 203–208
Ozçakar ZB, Yalçinkaya F, Yüksel S et al (2006) Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol 25:149–152
Savgan-Gürol E, Kasapçopur Ö, Hatemi S et al (2001) Growth and IGF-1 levels of children with familial Mediterranean fever on colchicine treatment. Clin Exp Rheumatol 19(Suppl 24):72–75
Simon D (2007) Management of growth retardation in juvenile idiopathic arthritis. Horm Res 68(Suppl 5):122–125
Türkmen M, Soylu ÖB, Kasap B et al (2008) Growth in familial Mediterranean fever: effect of attack rate, genotype and colchicine treatment. J Pediatr Endocrinol Metab 21:789–792
Underwood LE (1999) Growth retardation in chronic diseases: possible mechanisms. Acta Paediatr Suppl 428:93–96
Yalçınkaya F, Özen S, Özçakar ZB et al (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48:395–398
Zemer D, Livneh A, Danon Y et al (1991) Long term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 34:973–977
Zung A, Barash G, Zadik Z, Barash J (2006) Familial Mediterranean fever and growth: effect of disease severity and colchicine treatment. J Pediatr Endocrinol Metab 19:155–160
Conflict of interest
Authors have no conflict of intrest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özçakar, Z.B., Kadıoğlu, G., Şıklar, Z. et al. The effect of colchicine on physical growth in children wıth familial mediterranean fever. Eur J Pediatr 169, 825–828 (2010). https://doi.org/10.1007/s00431-009-1120-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-009-1120-z